Janney Capital Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Janney Capital Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-196,875	Closed	-$16.4M	–	241
2023 Q2	$16.4M	Sell	196,875 -6,164	-3%	-$515K	1.13%	24
2023 Q1	$15.5M	Sell	203,039 -6,695	-3%	-$556K	1.16%	24
2022 Q4	$17.4M	Sell	209,734 -8,991	-4%	-$728K	1.24%	20
2022 Q3	$17.3M	Buy	+218,725	New	+$18.4M	1.41%	18
2020 Q3	–	Sell	-3,383	Closed	-$379K	–	206
2020 Q2	$379K	Sell	3,383 -446	-12%	-$43.9K	0.03%	149
2020 Q1	$297K	Sell	3,829 -308	-7%	-$27.3K	0.02%	153
2019 Q4	$393K	Buy	+4,137	New	+$358K	0.02%	161
2019 Q3	–	Sell	-150,164	Closed	-$13.2M	–	225
2019 Q2	$13.2M	Sell	150,164 -7,745	-5%	-$661K	0.71%	62
2019 Q1	$14.3M	Buy	+157,909	New	+$13.4M	0.75%	51

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Janney Capital Management's XBI Position: Q3 2023 in Review

Janney Capital Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2023, closing a stake of 196,875 shares — an estimated $16.4M sold.

Janney Capital Management first reported a position in XBI in Q1 2019 and held it in 9 quarters. The position peaked at $17.4M in Q4 2022. 679 funds tracked by Wall St. Rank hold XBI as of Q3 2023.

Janney Capital Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2023 after selling out during the quarter.
Janney Capital Management sold 196,875 State Street SPDR S&P Biotech ETF shares in Q3 2023, an estimated $16.4M.
Janney Capital Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2019 and held it in 9 quarters.
Janney Capital Management's State Street SPDR S&P Biotech ETF position peaked at $17.4M in Q4 2022.
679 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2023.

Based on Janney Capital Management's 13F filing for Q3 2023, filed 8 Nov 2023.